CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 98 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2018. The put-call ratio across all filers is 0.96 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $6,000 | -75.0% | 32,600 | -39.0% | 0.01% | -66.7% |
| Q3 2018 | $24,000 | -11.1% | 53,400 | -1.8% | 0.02% | -10.0% |
| Q2 2018 | $27,000 | -78.9% | 54,400 | -1.1% | 0.02% | -80.2% |
| Q1 2018 | $128,000 | -26.0% | 55,000 | -9.8% | 0.10% | -25.2% |
| Q4 2017 | $173,000 | -6.5% | 61,000 | -5.9% | 0.14% | -6.2% |
| Q3 2017 | $185,000 | +15.6% | 64,800 | 0.0% | 0.14% | +14.3% |
| Q2 2017 | $160,000 | -31.6% | 64,800 | 0.0% | 0.13% | -31.9% |
| Q1 2017 | $234,000 | -0.8% | 64,800 | -3.0% | 0.18% | -5.6% |
| Q4 2016 | $236,000 | -12.9% | 66,800 | -0.3% | 0.20% | -4.4% |
| Q3 2016 | $271,000 | -7.8% | 67,000 | 0.0% | 0.20% | -14.6% |
| Q2 2016 | $294,000 | +7.3% | 67,000 | -7.6% | 0.24% | 0.0% |
| Q1 2016 | $274,000 | -13.3% | 72,500 | +259.8% | 0.24% | -10.1% |
| Q4 2015 | $316,000 | – | 20,150 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 1,025,000 | $24,815,000 | 31.36% |
| TSP Capital Management Group, LLC | 836,342 | $20,248,000 | 8.80% |
| Iguana Healthcare Management, LLC | 200,000 | $4,842,000 | 2.76% |
| First Light Asset Management, LLC | 116,096 | $2,811,000 | 2.38% |
| SECTORAL ASSET MANAGEMENT INC | 2,227,688 | $53,932,000 | 2.33% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 550,735 | $13,334,000 | 2.05% |
| Eventide Asset Management | 257,000 | $6,222,000 | 1.92% |
| Redmile Group, LLC | 397,951 | $9,634,000 | 1.19% |
| ARDSLEY ADVISORY PARTNERS LP | 357,000 | $8,643,000 | 1.15% |
| Rhenman & Partners Asset Management AB | 90,000 | $2,179,000 | 0.85% |